Former US Attorney General Pam Bondi’s recent health announcement reveals a thyroid cancer diagnosis, marking a significant pivot in her public life after leaving the Department of Justice.
Former US Attorney General Pam Bondi, who was removed from her role as the nation's top law enforcement officer last month, has been diagnosed with thyroid cancer. This medical announcement follows her dismissal from the Department of Justice, as reported by CBS News, a US partner of the BBC.
Her diagnosis arrived shortly after President Donald Trump ousted her from the post. Despite this health challenge, Bondi is continuing to work. She is set to join the White House's new advisory council on AI, officially known as the Presidential Council of Advisors on Science and Technology.
Podcast host and former White House adviser Katie Miller shared details of the diagnosis on social media. Miller stated that "Pam has been quietly kicking cancer's ass the last few weeks," praising the former attorney general's resilience. Miller added that Bondi "has a heart of gold," highlighting her personal character amidst professional transitions.
According to the Cleveland Clinic, thyroid cancer has a five-year survival rate of over 98%. The medical institution notes that most forms of the disease are treatable and permanently curable. However, it remains unclear what stage of cancer Bondi has been diagnosed with.
When Bondi left the Department of Justice at the beginning of April, she expressed excitement about entering a role in the private sector. Her inclusion on the president's council, known as PCAST, marks the first public news regarding her work beyond the department.
Vice-President JD Vance issued a statement regarding Bondi’s new position. Vance described her as "an enormously valuable asset to the president's team." He expressed thrill that she would remain involved in confronting important issues facing the administration.
Trump established PCAST by executive order in January 2025. He described its purpose as unifying the brightest minds from academia, industry, and government. The goal is to guide the nation through a critical moment by charting a path for American leadership in science and technology.
The first members of the council were not announced until March 2026. The council includes major players in the science and technology industries. These members include Google co-founder Sergey Brin, Meta CEO Mark Zuckerberg, Oracle co-founder Larry Ellison, and Nvidia CEO Jensen Huang.
Bondi, who has been fiercely loyal to Trump since his first term, brings a different perspective to this scientific advisory body. Her appointment signals a broadening of the council's focus or the inclusion of diverse legal and administrative expertise in technology policy.
While navigating her health diagnosis and new role, Bondi faces significant political obligations. She is scheduled to testify before the House Oversight Committee on Friday. The testimony will concern her handling of the Epstein files.
Both Bondi and Trump have received bipartisan criticism over the justice department's release of the Epstein files. Some Democratic lawmakers have argued that important files were withheld from the public. This oversight continues to be a point of contention in ongoing political discourse.
Bondi is one of four members of Trump's cabinet to have left their positions so far this year. Her departure follows the removal of Kristi Noem as Secretary of Homeland Security. Additionally, Lori Chavez-DeRemer served as labour secretary before her exit. This pattern of cabinet turnover highlights the fluid nature of the current administration's leadership structure.
The intersection of health, high-level government service, and ongoing legal scrutiny creates a complex narrative for Bondi. Her ability to manage a serious medical condition while preparing for congressional testimony underscores the demands placed on former senior officials.
The diagnosis of thyroid cancer comes at a time when Bondi is stepping into a new advisory capacity. This move away from direct law enforcement leadership toward scientific advisory roles represents a significant career shift. It also coincides with a period of intense public and political examination of her tenure.
As Bondi prepares for her testimony and begins her work with PCAST, the focus remains on her contributions to both science policy and legal transparency. The survival rates associated with her diagnosis offer hope, but the political and professional challenges remain substantial.
Former Attorney General Pam Bondi’s transition from the Department of Justice to the Presidential Council on Science and Technology coincides with a personal health crisis. Her diagnosis of a treatable yet serious condition highlights the resilience required in high-stakes government roles. As she prepares to advise on critical AI and technology issues alongside tech giants like Zuckerberg and Brin, her upcoming testimony on the Epstein files will test her public standing. This dual focus on advancing American technology leadership while managing personal health and legal obligations suggests a future where Bondi continues to influence national policy from within the administration’s scientific advisory framework, despite the recent turmoil in the cabinet.
Jun 8, 2026 04:15 UTC
Trump Urges Netanyahu to Halt Iran Strike for Peace
Join 50,000+ readers getting the global briefing every morning.
No spam. Unsubscribe anytime.
Jun 8, 2026 02:28 UTC
Trump Walks Out of Meet the Press After Rejecting Evidence Demands
Jun 8, 2026 02:17 UTC
Magnitude 7.8 Quake Shakes Philippines, Urging Immediate Evacuations
Jun 8, 2026 00:51 UTC
Trump Claims Iran Nuclear Deal Imminent Despite Diplomatic Fractures
Jun 8, 2026 00:47 UTC
Iran Fires Missiles at Israel After Beirut Strike
